Carol Schafer is of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 59,665 shares of IDRA, which is worth approximately $179,591. The most recent transaction as insider was on Apr 01, 2021, when has been sold 11,177 shares (Common Stock) at a price of $1.32 per share, resulting in proceeds of $14,754. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.7K
0% 3M change
0% 12M change
Total Value Held $179,591

CAROL SCHAFER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 01 2021
BUY
Grant, award, or other acquisition
$14,754 $1.32 p/Share
11,177 Added 15.78%
59,665 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
$14,552 $4.02 p/Share
3,620 Added 6.95%
48,488 Common Stock
Oct 01 2020
BUY
Grant, award, or other acquisition
$13,750 $2.25 p/Share
6,111 Added 11.99%
44,868 Common Stock

Also insider at

INSM
INSMED Inc Healthcare
KURA
Kura Oncology, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
IMNM
Immunome Inc. Healthcare
FPRX
FIVE PRIME THERAPEUTICS, INC.
CS

Carol Schafer

Bridgewater, NJ

Track Institutional and Insider Activities on IDRA

Follow IDERA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDRA shares.

Notify only if

Insider Trading

Get notified when an Idera Pharmaceuticals, Inc. insider buys or sells IDRA shares.

Notify only if

News

Receive news related to IDERA PHARMACEUTICALS, INC.

Track Activities on IDRA